Clinical Research

Learn more about ongoing clinical trials involving Genmab products. Use the options below to choose which trials you wish to view.

The safety and efficacy of investigational agents and/or investigational uses of approved products have not been established.

DuoBody®-CD3xB7H4 (GEN1047)
Cancer Type:
Solid Tumors
DuoBody®-CD40x4-1BB (GEN1042)
Cancer Type:
Solid Tumors
DuoBody®-PD-L1x4-1BB (GEN1046)
Cancer Type:
Solid Tumors
DuoHexaBody®-CD37 (GEN3009)
Cancer Type:
Hematologic Malignancies
Epcoritamab
Cancer Type:
Hematologic Malignancies
HexaBody®-CD38 (GEN3014)
Cancer Type:
Hematologic Malignancies
Tisotumab Vedotin
Cancer Type:
Solid Tumors

Pre-approval access

Eligible patients may be able to access products prior to approval or launch.

Pipeline

Review our products currently in development.

Investigator-sponsored trials

Submit your research concept by visiting our online portal.

Genmab logo.

Contact Us

Select office location:

Denmark

  • Denmark
  • Netherlands
  • USA
  • Japan

Genmab A/S

Kalvebod Brygge 43
1560 Copenhagen V
Denmark
Phone +45 7020 2728

CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122

Genmab A/S

Visiting Address
Uppsalalaan 15
3584 CT Utrecht
The Netherlands

Postal Address
P.O. Box 85199
3508 AD Utrecht
The Netherlands

Phone: +31 30 2 123 123
LCVR Utrecht 30169902
VAT no. NL8095.75.000.B.01

Genmab US, Inc.

777 Scudders Mill Road
Plainsboro, NJ 08536
USA
Phone +1 609 430 2481

Genmab K.K.

Midtown Tower
9-7-1 Akasaka, Minato-ku
Tokyo 107-6235
Japan

Website
Chamber of Commerce no.: 0104-01-14036

Have a general inquiry? Contact Us.
We will handle your personal data in accordance with our Privacy Policy.